Cargando…

The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia

The impact of body mass index (BMI) at diagnosis on treatment outcome in children with acute lymphoblastic leukemia (ALL) is controversial. We studied 373 children with ALL enrolled on the Total XV study, which prospectively used minimal residual disease (MRD) for risk assignment. MRD on day 19 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eissa, H M, Zhou, Y, Panetta, J C, Browne, E K, Jeha, S, Cheng, C, Relling, M V, Campana, D, Pui, C-H, Inaba, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533940/ https://www.ncbi.nlm.nih.gov/pubmed/28212374 http://dx.doi.org/10.1038/bcj.2017.11

Ejemplares similares

Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemia
por: Hu, Wenting, et al.
Publicado: (2022)

A Revised Definition for Cure of Childhood Acute Lymphoblastic Leukemia
por: Pui, CH, et al.
Publicado: (2014)

Modeling Mechanisms of In Vivo Variability in Methotrexate Accumulation and Folate Pathway Inhibition in Acute Lymphoblastic Leukemia Cells
por: Panetta, John C., et al.
Publicado: (2010)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
por: Karol, Seth E., et al.
Publicado: (2021)

Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome
por: Iijima, Mayuko, et al.
Publicado: (2022)

Population PK/PD Model of Homocysteine Concentrations after High-Dose Methotrexate Treatment in Patients with Acute Lymphoblastic Leukemia
por: Rühs, Hauke, et al.
Publicado: (2012)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Wang, Bei, et al.
Publicado: (2022)

Long-term results of St. Jude Total Therapy studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
por: Pui, C-H, et al.
Publicado: (2009)

Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy
por: Pui, Ching-Hon, et al.
Publicado: (2016)

In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile
por: Sorich, Michael J, et al.
Publicado: (2008)

Extreme body mass index and survival in newly diagnosed multiple myeloma patients
por: Shah, Urvi A., et al.
Publicado: (2023)

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Inaba, Hiroto, et al.
Publicado: (2021)

Increased Body Mass Index during Therapy for Childhood Acute Lymphoblastic Leukemia: A Significant and Underestimated Complication
por: Atkinson, Helen C., et al.
Publicado: (2015)

Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
por: Lee, Shawn H. R., et al.
Publicado: (2023)

Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia
por: Ramsey, Laura B., et al.
Publicado: (2015)

Urinary BK Virus Excretion in Children Newly Diagnosed with Acute Lymphoblastic Leukemia
por: Raeesi, Nahid, et al.
Publicado: (2012)

D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia
por: Anderson, Daniela R., et al.
Publicado: (2022)

Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
por: Gruber, Tanja A., et al.
Publicado: (2022)

Association between body mass index and insulin resistance in survivors of pediatric acute lymphoblastic leukemia
por: Bahoush, Gholamreza, et al.
Publicado: (2020)

Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
por: Bhattarai, Kashi Raj, et al.
Publicado: (2023)

Obesity and height in children and adolescents with acute lymphoblastic leukemia and its future management
por: Browne, Emily K., et al.
Publicado: (2019)

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
por: Camm, Christian Fielder, et al.
Publicado: (2022)

Steroid-associated bradycardia in a newly diagnosed B precursor acute lymphoblastic leukemia patient with Holt–Oram syndrome
por: Morales, Raymond, et al.
Publicado: (2020)

Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2017)

1155. Covering Your Tracts? The Effect of Antibiotic Prophylaxis on Respiratory Tract Infections in Pediatric Acute Lymphoblastic Leukemia
por: Strength, Rachel, et al.
Publicado: (2021)

Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures
por: Barnett, Kelly R., et al.
Publicado: (2023)

Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia
por: Ferguson, Daniel C., et al.
Publicado: (2022)

Performance of newly developed body mass index cut-off for diagnosing obesity among Ethiopian adults
por: Sinaga, Makeda, et al.
Publicado: (2019)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
por: Hu, Min, et al.
Publicado: (2023)

Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols
por: Egnell, Christina, et al.
Publicado: (2020)

Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol
por: Egnell, Christina, et al.
Publicado: (2022)

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children
por: Escherich, Carolin, et al.
Publicado: (2023)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Correlation of HbA(1C) Levels With Body Mass Index in Newly Diagnosed Polycystic Ovary Syndrome
por: Bala, Manju, et al.
Publicado: (2017)

Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
por: DeAngelo, D J, et al.
Publicado: (2015)

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients
por: Advani, Anjali S, et al.
Publicado: (2010)

A Case of Primary Multifocal Cutaneous Mucormycosis in a Pediatric Patient with Newly Diagnosed Acute Lymphoblastic Leukemia
por: Niyazi, Denis, et al.
Publicado: (2023)

Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2020)

Precision medicine in acute lymphoblastic leukemia
por: Pui, Ching-Hon
Publicado: (2020)

Difficulties in diagnosing of measles inclusion body encephalitis in a child with acute lymphoblastic leukemia
por: Lytvyn, Halyna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pr26k1gbo63fr5utrg9utv1cat